SALUS, Ljubljana, d. d. (LJSE:SALR)

Market Cap	341.92M
Revenue (ttm)	649.36M
Net Income (ttm)	13.15M
Shares Out	8.22M
EPS (ttm)	1.61
PE Ratio	25.87
Forward PE	n/a
Dividend	1.03 (2.47%)
Ex-Dividend Date	Apr 25, 2025

Volume	7
Average Volume	572
Open	41.60
Previous Close	41.40
Day's Range	41.60 - 41.60
52-Week Range	25.39 - 46.00
Beta	0.43
RSI	65.43
Earnings Date	Aug 12, 2025

About SALUS, Ljubljana, d. d.

SALUS, Ljubljana, d. d. engages in the provision of distribution, promotion, active sales, and value-added services for the medicinal products in Slovenia and internationally. The company offers medicines, medical devices, diagnostic devices, medical supplies, sanitary products, dietary supplements, cosmetic products, pharmaceutical packaging’s, and other health and well-being related products to pharmacies, hospitals, community health centers, residential homes, veterinary institutions, and other customers. It also provides distribution, stora...

• Industry: Drugs, Drug Proprietaries, and Druggists' Sundries
• Founded: 1969
• Employees: 618
• Stock Exchange: Ljubljana Stock Exchange
• Ticker Symbol: SALR

Financial Performance

In 2024, SALUS, Ljubljana, d. d.'s revenue was 648.83 million, an increase of 8.24% compared to the previous year's 599.44 million. Earnings were 12.85 million, an increase of 25.14%.